Andrew Broda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andrew Broda has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Zachary Sanford
Department of Surgery, Anne Arundel Medical Center, Annapolis, MD, USA
9 shared publicationsAlex Addo
Department of Surgery, Anne Arundel Medical Center, School of Medicine, Johns Hopkins University, 2000 Medical Parkway, Belcher Pavilion, Suite 106, Annapolis, MD, 21401, USA
5 shared publicationsRichard Lu
Department of Surgery, Anne Arundel Medical Center, 2000 Medical Parkway, Suite 100, Annapolis, MD, 21401, USA
5 shared publicationsAlex J. Addo
4 shared publicationsH. Reza Zahiri
Department of Surgery, Anne Arundel Medical Center, School of Medicine, Johns Hopkins University, 2000 Medical Parkway, Belcher Pavilion, Suite 106, Annapolis, MD, 21401, USA
4 shared publications- Adrian Park
Anne Arundel Medical Center
3 shared publications
Latest Publications
- Open Access
- 9 November 2023
- Published by Springer Nature in Cureus
- Vol. 15 (11) , e48585
Barriers to Receiving Applied Behavior Analysis Services in Children With Autism Spectrum Disorder
Introduction Applied behavior analysis (ABA) is commonly used to treat children with autism spectrum disorder (ASD). The objective of this study is to evaluate barriers to ABA treatment in ASD. Methods A voluntary 51-question survey, including demographics, socioeconomic status, parental assertiveness/self-advocacy, and parent perceptions, was provided to caregivers of children aged one to eight years old diagnosed with ASD. The survey consisted of a series of yes/no, five-point Likert scale, multiple-choice, and text field questions. Results A total of 540 surveys were completed. The median time since ASD diagnosis was three to five years ago. Respondents were identified as receiving ABA (r-ABA) vs. not receiving ABA (n-ABA). Respondents were from Florida (60%; r-ABA = 61.7%; n-ABA = 57.0%), Pennsylvania (18%; r-ABA = 21.3%; n-ABA = 12.8%), Delaware (17%; r-ABA = 11.7%; n-ABA = 26.8%), and New Jersey (5%; r-ABA = 5.3%; n-ABA = 3.4%) (p < 0.001). Caregiver belief in ABA treatment, empowerment, and comfort level were greater for r-ABA (4.20 ± 0.72; 3.19 ± 0.93; 4.35 ± 0.72) compared to n-ABA (4.06 ± 0.83; 2.90 ± 1.00; 4.03 ± 0.91), respectively (mean ± SD). Conclusion Barriers to accessing ABA services are a multifactorial issue. Location, income, education of the caregiver, time since ASD diagnosis for the child, as well as caregiver empowerment, belief in treatment, and level of comfort in accessing services most likely contribute to children with ASD not receiving ABA. Empowering parents on their impact on their child’s treatment may improve ABA use.
- 9 November 2023
- Published by Springer Nature in Cureus
- Vol. 15 (11) , e48585
Open AccessBarriers to Receiving Applied Behavior Analysis Services in Children With Autism Spectrum Disorder
Introduction Applied behavior analysis (ABA) is commonly used to treat children with autism spectrum disorder (ASD). The objective of this study is to evaluate barriers to ABA treatment in ASD. Methods A voluntary 51-question survey, including demographics, socioeconomic status, parental assertiveness/self-advocacy, and parent perceptions, was provided to caregivers of children aged one to eight years old diagnosed with ASD. The survey consisted of a series of yes/no, five-point Likert scale, multiple-choice, and text field questions. Results A total of 540 surveys were completed. The median time since ASD diagnosis was three to five years ago. Respondents were identified as receiving ABA (r-ABA) vs. not receiving ABA (n-ABA). Respondents were from Florida (60%; r-ABA = 61.7%; n-ABA = 57.0%), Pennsylvania (18%; r-ABA = 21.3%; n-ABA = 12.8%), Delaware (17%; r-ABA = 11.7%; n-ABA = 26.8%), and New Jersey (5%; r-ABA = 5.3%; n-ABA = 3.4%) (p < 0.001). Caregiver belief in ABA treatment, empowerment, and comfort level were greater for r-ABA (4.20 ± 0.72; 3.19 ± 0.93; 4.35 ± 0.72) compared to n-ABA (4.06 ± 0.83; 2.90 ± 1.00; 4.03 ± 0.91), respectively (mean ± SD). Conclusion Barriers to accessing ABA services are a multifactorial issue. Location, income, education of the caregiver, time since ASD diagnosis for the child, as well as caregiver empowerment, belief in treatment, and level of comfort in accessing services most likely contribute to children with ASD not receiving ABA. Empowering parents on their impact on their child’s treatment may improve ABA use.
- 1 November 2021
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 233 (5) , e159
Cleft Palate Repair Outcomes in Patients with 22q11 Deletion Syndrome: A NSQIP Pediatric Analysis
- 1 November 2021
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 233 (5) , e159
Cleft Palate Repair Outcomes in Patients with 22q11 Deletion Syndrome: A NSQIP Pediatric Analysis
- 1 June 2021
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (6) , 2515-2522
The impact of laparoscopic anti-reflux surgery on quality of life: do patients with atypical symptoms benefit?
Introduction Gastroesophageal reflux disease (GERD) may manifest atypically as cough, hoarseness or difficulty breathing. However, it is difficult to diagnostically establish a cause-and-effect between atypical symptoms and GERD. In addition, the benefit of laparoscopic anti-reflux surgery (LARS) in patients with laryngopharyngeal manifestations of GERD are not well characterized. We report the largest series reported to date assessing operative and quality of life (QOL) outcomes after LARS in patients experiencing extraesophageal manifestations of GERD and discuss recommendations for this patient population. Methods A retrospective review of patients with extraesophageal symptoms and pathologic reflux that underwent LARS between February 2012 and July 2019 was conducted. Inclusion criteria consisted of patients with atypical manifestations of GERD as defined by preoperative survey in addition to physiological diagnosis of pathological reflux. Patient QOL outcomes was analyzed using four validated instruments: the Reflux Symptom Index (RSI), Laryngopharyngeal Reflux QOL, Swallowing QOL (SWAL), and Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQOL) surveys. Results 420 patients (24% male, 76% female) with a mean age of 61.7 +/- 13.0 years and BMI of 28.6 +/- 5.0 kg/m(2)were included in this study. Thirty-day wound (0.2%) and non-wound (6.74%) related complication rates were recorded in addition to thirty-day readmission rate (2.6%). Patients reported significant improvements in laryngopharyngeal symptoms at mean follow-up of 18.9 +/- 16.6 months post LARS reflected by results of four QOL instruments (RSI - 64%, LPR - 75%, GERD-HRQOL - 80%, SWAL + 18%). The majority of patients demonstrated complete resolution of symptoms upon subsequent encounters with 68% of patients reporting no atypical extraesophageal manifestations during follow-up survey (difficulty breathing - 86%, chronic cough - 81%, hoarseness - 66%, globus sensation - 68%) and 68% of patients no longer taking anti-reflux medication. Seventy-two percent of patients reported being satisfied with their symptom control at latest follow-up. Conclusions In appropriately selected candidates with atypical GERD symptomatology and objective diagnosis of GERD LARS may afford significant QOL improvements with minimal operative or long-term morbidity.
- 1 June 2021
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (6) , 2515-2522
The impact of laparoscopic anti-reflux surgery on quality of life: do patients with atypical symptoms benefit?
Introduction Gastroesophageal reflux disease (GERD) may manifest atypically as cough, hoarseness or difficulty breathing. However, it is difficult to diagnostically establish a cause-and-effect between atypical symptoms and GERD. In addition, the benefit of laparoscopic anti-reflux surgery (LARS) in patients with laryngopharyngeal manifestations of GERD are not well characterized. We report the largest series reported to date assessing operative and quality of life (QOL) outcomes after LARS in patients experiencing extraesophageal manifestations of GERD and discuss recommendations for this patient population. Methods A retrospective review of patients with extraesophageal symptoms and pathologic reflux that underwent LARS between February 2012 and July 2019 was conducted. Inclusion criteria consisted of patients with atypical manifestations of GERD as defined by preoperative survey in addition to physiological diagnosis of pathological reflux. Patient QOL outcomes was analyzed using four validated instruments: the Reflux Symptom Index (RSI), Laryngopharyngeal Reflux QOL, Swallowing QOL (SWAL), and Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQOL) surveys. Results 420 patients (24% male, 76% female) with a mean age of 61.7 +/- 13.0 years and BMI of 28.6 +/- 5.0 kg/m(2)were included in this study. Thirty-day wound (0.2%) and non-wound (6.74%) related complication rates were recorded in addition to thirty-day readmission rate (2.6%). Patients reported significant improvements in laryngopharyngeal symptoms at mean follow-up of 18.9 +/- 16.6 months post LARS reflected by results of four QOL instruments (RSI - 64%, LPR - 75%, GERD-HRQOL - 80%, SWAL + 18%). The majority of patients demonstrated complete resolution of symptoms upon subsequent encounters with 68% of patients reporting no atypical extraesophageal manifestations during follow-up survey (difficulty breathing - 86%, chronic cough - 81%, hoarseness - 66%, globus sensation - 68%) and 68% of patients no longer taking anti-reflux medication. Seventy-two percent of patients reported being satisfied with their symptom control at latest follow-up. Conclusions In appropriately selected candidates with atypical GERD symptomatology and objective diagnosis of GERD LARS may afford significant QOL improvements with minimal operative or long-term morbidity.
- 13 March 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (1) , 429-436
Age-related outcomes in laparoscopic hiatal hernia repair: Is there a “too old” for antireflux surgery?
Background Minimally invasive antireflux surgery has been shown to be safe and effective for the treatment of gastroesophageal reflux (GERD) in elderly patients. However, there is a paucity of data on the influence of advanced age on long-term quality of life (QoL) and perioperative outcomes after laparoscopic antireflux surgery (LARS). Method A retrospective study of patients undergoing LARS between February 2012 and June 2018 at a single institution was conducted. Patients were divided into four age categories. Perioperative data and quality of life (QOL) outcomes were collected and analyzed. Results A total of 492 patients, with mean follow-up of 21 months post surgery, were included in the final analysis. Patients were divided into four age-determined subgroups (< 50:75, 50–65:179, 65–75:144, ≥ 75:94). Advancing age was associated with increasing likelihood of comorbid disease. Older patients were significantly more likely to require Collis gastroplasty (OR 2.09), or concurrent gastropexy (OR 3.20). Older surgical patients also demonstrated increased operative time (ß 6.29, p < .001), length of hospital stay (ß 0.56, p < .001) in addition to increased likelihood of intraoperative complications (OR 2.94, p = .003) and reoperations (OR 2.36, p < .05). However, postoperative QoL outcomes and complication rates were parallel among all age groups. Conclusions Among older patients, there is a greater risk of intraoperative complications, reoperation rates as well as longer operative time and LOS after LARS. However, a long-term QoL benefit is demonstrated among elderly patients who have undergone this procedure. Rather than serving as an exclusion criterion for surgical intervention, advanced age among chronic reflux patients should instead represent a comorbidity addressed in the planning stages of LARS.
- 13 March 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (1) , 429-436
Age-related outcomes in laparoscopic hiatal hernia repair: Is there a “too old” for antireflux surgery?
Background Minimally invasive antireflux surgery has been shown to be safe and effective for the treatment of gastroesophageal reflux (GERD) in elderly patients. However, there is a paucity of data on the influence of advanced age on long-term quality of life (QoL) and perioperative outcomes after laparoscopic antireflux surgery (LARS). Method A retrospective study of patients undergoing LARS between February 2012 and June 2018 at a single institution was conducted. Patients were divided into four age categories. Perioperative data and quality of life (QOL) outcomes were collected and analyzed. Results A total of 492 patients, with mean follow-up of 21 months post surgery, were included in the final analysis. Patients were divided into four age-determined subgroups (< 50:75, 50–65:179, 65–75:144, ≥ 75:94). Advancing age was associated with increasing likelihood of comorbid disease. Older patients were significantly more likely to require Collis gastroplasty (OR 2.09), or concurrent gastropexy (OR 3.20). Older surgical patients also demonstrated increased operative time (ß 6.29, p < .001), length of hospital stay (ß 0.56, p < .001) in addition to increased likelihood of intraoperative complications (OR 2.94, p = .003) and reoperations (OR 2.36, p < .05). However, postoperative QoL outcomes and complication rates were parallel among all age groups. Conclusions Among older patients, there is a greater risk of intraoperative complications, reoperation rates as well as longer operative time and LOS after LARS. However, a long-term QoL benefit is demonstrated among elderly patients who have undergone this procedure. Rather than serving as an exclusion criterion for surgical intervention, advanced age among chronic reflux patients should instead represent a comorbidity addressed in the planning stages of LARS.
- 11 October 2019
- Published by Springer Nature in Surgical Endoscopy
- Vol. 34 (8) , 3597-3605
Comparative review of outcomes: laparoscopic and robotic enhanced-view totally extraperitoneal (eTEP) access retrorectus repairs
Building on the principles of eTEP access, described by Dr. Jorge Daes, our group has previously described and standardized a novel minimally invasive approach to restoration of the linea alba and repair of lateral atypical defects of the abdominal wall. The purpose of this report is to present comparative analysis of laparoscopic and robotic eTEP access retrorectus repairs.
- 11 October 2019
- Published by Springer Nature in Surgical Endoscopy
- Vol. 34 (8) , 3597-3605
Comparative review of outcomes: laparoscopic and robotic enhanced-view totally extraperitoneal (eTEP) access retrorectus repairs
Building on the principles of eTEP access, described by Dr. Jorge Daes, our group has previously described and standardized a novel minimally invasive approach to restoration of the linea alba and repair of lateral atypical defects of the abdominal wall. The purpose of this report is to present comparative analysis of laparoscopic and robotic eTEP access retrorectus repairs.
- 1 October 2019
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (10) , S187
A455 Aerosolized fibrin sealant does not reduce risk of staple line bleeding following laparoscopic sleeve gastrectomy
- 1 October 2019
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (10) , S187
A455 Aerosolized fibrin sealant does not reduce risk of staple line bleeding following laparoscopic sleeve gastrectomy
- 1 October 2019
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (10) , S145-S146
A354 Investigating weight-related outcomes following Laparoscopic Roux-en-Y Gastric Bypass utilizing the ACS MBSAQIP
- 1 October 2019
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (10) , S145-S146
A354 Investigating weight-related outcomes following Laparoscopic Roux-en-Y Gastric Bypass utilizing the ACS MBSAQIP
- 1 October 2019
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (10) , S237-S238
A579 Investigating weight-related outcomes following Laparoscopic Sleeve Gastrectomy utilizing the ACS MBSAQIP
- 1 October 2019
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (10) , S237-S238
A579 Investigating weight-related outcomes following Laparoscopic Sleeve Gastrectomy utilizing the ACS MBSAQIP
- 1 October 2019
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (10) , S19-S20
A129 Comparison of Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-Y Gastric Bypass outcomes utilizing the ACS MBSAQIP
- 1 October 2019
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (10) , S19-S20
A129 Comparison of Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-Y Gastric Bypass outcomes utilizing the ACS MBSAQIP
- 1 October 2019
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (10) , S40-S41
A162 Investigation of Laparoscopic Sleeve Gastrectomy with and without concurrent Paraesophageal Hiatal Hernia Repair utilizing the ACS MBSAQIP
- 1 October 2019
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (10) , S40-S41
A162 Investigation of Laparoscopic Sleeve Gastrectomy with and without concurrent Paraesophageal Hiatal Hernia Repair utilizing the ACS MBSAQIP